Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoimmunity and interstitial lung disease.

Surinder K Jindal1, Ritesh Agarwal

  • 1Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh-160012, India. skjindal@indeachest.org

Current Opinion in Pulmonary Medicine
|August 12, 2005
PubMed
Summary

Autoimmunity may play a role in idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases. Further research is needed to understand autoimmunity

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Benralizumab as a First-line Treatment for ABPA: Is It Really Indicated?

Internal medicine (Tokyo, Japan)·2021
Same author

Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature.

Mycopathologia·2021
Same author

Iodopovidone pleurodesis for malignant pleural effusions: an updated systematic review and meta-analysis.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2021
Same author

Is high-dose glucocorticoid beneficial in COVID-19?

The European respiratory journal·2021
Same author

False equivalence of four-month and six-month ATT regimen: a case of comparing apples and oranges.

Tropical medicine & international health : TM & IH·2021
Same author

Large pulmonary artery pseudoaneurysm in mucormycosis: successfully managed with surgery and amphotericin.

BMJ case reports·2021

Area of Science:

  • Immunology
  • Pulmonary Medicine
  • Pathogenesis of Lung Diseases

Background:

  • The exact causes of idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases (ILDs) remain unclear.
  • Autoimmunity is a known factor in ILDs associated with connective tissue disorders like systemic sclerosis, lupus, and rheumatoid arthritis.
  • Emerging evidence suggests autoimmunity may contribute to alveolar injury in IPF.

Purpose of the Study:

  • To review existing literature on the role of autoimmunity in the pathogenesis of IPF.
  • To explore the potential mechanisms by which autoimmunity contributes to lung injury and fibrosis.
  • To highlight the underinvestigated nature of autoimmunity in ILDs.

Main Methods:

  • Literature review of studies investigating autoimmunity in IPF and related ILDs.

Related Experiment Videos

  • Analysis of autoantibody presence in IPF patients.
  • Examination of autoimmune mechanisms in connective tissue disease-associated ILDs.
  • Consideration of autoimmunity in lung transplant rejection.

    • Main Results:

    • Autoantibodies have been detected in the sera of some IPF patients.
    • Specific autoantibodies (anti-Sm, anti-U1 RNP, anti-U3 RNP) are linked to connective tissue disorders with lung involvement.
    • Autoimmunity is implicated as a potential cause of bronchiolitis obliterans after lung transplantation.

    Conclusions:

    • The role of autoimmunity in ILDs, including IPF, may be underestimated.
    • Further investigation is crucial, particularly concerning non-alloimmune bronchiolitis obliterans and IPF treatment resistance.
    • Understanding autoimmune mechanisms could lead to novel therapeutic strategies for ILDs.